Venetoclax-obinutuzumab: harnessing complexity

Blood. 2020 Mar 12;135(11):788-789. doi: 10.1182/blood.2019004463.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Bridged Bicyclo Compounds, Heterocyclic
  • Humans
  • Karyotype
  • Leukemia, Lymphocytic, Chronic, B-Cell*
  • Sulfonamides

Substances

  • Antibodies, Monoclonal, Humanized
  • Bridged Bicyclo Compounds, Heterocyclic
  • Sulfonamides
  • venetoclax
  • obinutuzumab